Cite
Using terahertz pulsed spectroscopy to quantify pharmaceutical polymorphism and crystallinity
MLA
Philip F. Taday, et al. “Using Terahertz Pulsed Spectroscopy to Quantify Pharmaceutical Polymorphism and Crystallinity.” Journal of Pharmaceutical Sciences, vol. 94, no. 4, Mar. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e4e296f5fd2e1eda0315c61297687a90&authtype=sso&custid=ns315887.
APA
Philip F. Taday, J. Axel Zeitler, Thomas Rades, David A. Newnham, Michael Pepper, Keith C. Gordon, & Clare J. Strachan. (2005). Using terahertz pulsed spectroscopy to quantify pharmaceutical polymorphism and crystallinity. Journal of Pharmaceutical Sciences, 94(4).
Chicago
Philip F. Taday, J. Axel Zeitler, Thomas Rades, David A. Newnham, Michael Pepper, Keith C. Gordon, and Clare J. Strachan. 2005. “Using Terahertz Pulsed Spectroscopy to Quantify Pharmaceutical Polymorphism and Crystallinity.” Journal of Pharmaceutical Sciences 94 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e4e296f5fd2e1eda0315c61297687a90&authtype=sso&custid=ns315887.